408
H. Jin
Table 14.1
(continued)
Characters
Merits
Demerits
Merits
Demerits
Interaction Flexibility 1. Renature easily after
denaturation
2. Pharmacokinetic parameters
can be changed on demand
3. Produced in a controlled
manner
4. No affinity loss after
modification of aptamers
N/A
N/A
1. Cannot renature after
denaturation
2. Cannot change
pharmacokinetic
parameters on demand
3. Produced in an
uncontrolled manner
Safety related
Nature structure has no
immunogenicity and toxicity
N/A
N/A
May have immunogenicity or
toxicity
Molecular Size
1. Small
2. High tissue penetration
capacity
Rapidly excreted by the
kidneys
N/A
1. Large
2. A limited tissue
penetration capacity
Specificity
Single point mutation
identifiable
Cross reactive with its
analogues
N/A
Different antibody might bind
same antigen
H. Jin
Table 14.1
(continued)
Characters
Merits
Demerits
Merits
Demerits
Interaction Flexibility 1. Renature easily after
denaturation
2. Pharmacokinetic parameters
can be changed on demand
3. Produced in a controlled
manner
4. No affinity loss after
modification of aptamers
N/A
N/A
1. Cannot renature after
denaturation
2. Cannot change
pharmacokinetic
parameters on demand
3. Produced in an
uncontrolled manner
Safety related
Nature structure has no
immunogenicity and toxicity
N/A
N/A
May have immunogenicity or
toxicity
Molecular Size
1. Small
2. High tissue penetration
capacity
Rapidly excreted by the
kidneys
N/A
1. Large
2. A limited tissue
penetration capacity
Specificity
Single point mutation
identifiable
Cross reactive with its
analogues
N/A
Different antibody might bind
same antigen
